Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB06069_nanopub.RAnshmMHRkXERt5GJpa1jN_p1U_1U7L5aperloarzmoLo#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB06069 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06069 label "XMT-1001 [drugbank:DB06069]" assertion.
- drugbank:DB06069 seeAlso DB06069 assertion.
- drugbank:DB06069 description "XMT-1001 is a polymer-based prodrug of camptothecin (CPT), a well-characterized topoisomerase I inhibitor with potent anti-tumor activity. It is a water-soluble macromolecular conjugate of camptothecin (CPT). In this novel CPT pro-drug, CPT is conjugated with a 70 kDa biodegradable hydrophilic polyacetal, poly (1-hydroxymethylene hydroxylmethylformal). XMT-1001 has demonstrated an improved therapeutic window as compared with CPT and irinotecan in human tumor xenografts models" assertion.
- drugbank:DB06069 identifier "drugbank:DB06069" assertion.
- drugbank:DB06069 title "XMT-1001" assertion.
- drugbank:DB06069 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB06069 drugbank_vocabulary:drugbank-id "DB06069" assertion.
- drugbank:DB06069 bio2rdf_vocabulary:x-identifiers.org DB06069 assertion.
- drugbank:DB06069 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06069" assertion.
- drugbank:DB06069 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06069 bio2rdf_vocabulary:identifier "DB06069" assertion.